1. Home
  2. ALIT vs YDES Comparison

ALIT vs YDES Comparison

Compare ALIT & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alight Inc.

ALIT

Alight Inc.

HOLD

Current Price

$16.98

Market Cap

568.2M

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$2.17

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALIT
YDES
Founded
2017
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
568.2M
543.0M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ALIT
YDES
Price
$16.98
$2.17
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$3.75
N/A
AVG Volume (30 Days)
714.3K
311.7K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
21.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,262,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$1.70
52 Week High
$23.68
$25.00

Technical Indicators

Market Signals
Indicator
ALIT
YDES
Relative Strength Index (RSI) 56.14 47.05
Support Level $1.12 $1.93
Resistance Level $23.68 $3.05
Average True Range (ATR) 1.71 0.33
MACD -0.90 0.06
Stochastic Oscillator 2.91 44.44

Price Performance

Historical Comparison
ALIT
YDES

About ALIT Alight Inc.

Alight Inc is a technology-enabled services company delivering human capital management solutions to many complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth, and leave benefits) solutions, which currently operate under one reportable segment, Employer Solutions. The Employer Solutions segment is driven by the Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial well-being, leave of absence management, and retiree healthcare. Geographically, the company generates the majority of its revenue from the United States.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: